Table 1.
Characteristics of Nine Hundred Eighty Women at the Index Visit, Between April and October 1999
| Characteristica | HIV-infected n = 775b | HIV-uninfected n = 205 | pc |
|---|---|---|---|
| Race, n (%):d | 0.07 | ||
| Black | 457 (59%) | 118 (58%) | |
| Hispanic | 147 (19%) | 52 (25%) | |
| White | 171 (22%) | 35 (17%) | |
| Age, years | 41 (36, 46) | 39 (34, 44) | <0.01 |
| Height, cm | 163 (157, 168) | 163 (157, 168) | 0.09 |
| Weight, kg | 68 (59, 81) | 76 (61, 90) | <0.01 |
| Body fat, % | 38 (32, 45) | 42 (34, 48) | <0.01 |
| Upper arm, cm | 29 (26, 32) | 30 (27, 34) | 0.02 |
| Chest, cm | 92 (86, 99) | 93 (84, 101) | 0.54 |
| Waist, cm | 89 (80, 99) | 91 (79, 102) | 0.37 |
| Hip, cm | 97 (90, 106) | 104 (94, 113) | <0.01 |
| Thigh, cm | 50 (45, 55) | 52 (47, 59) | <0.01 |
| Nadir CD4 cell count, cells/mm3 | 243 (128, 385) | 798 (601, 978) | <0.01 |
| HIV-1 RNA, copies/mL | 1400 (80, 16000) | NA | |
| Clinical AIDS, n (%) | 360 (46%) | NA | |
| ARV use at index visit, n (%) | 514 (70%) | NA | |
| HAARTe use at index visit, n (%) | 402 (55%) | NA |
Median (interquartile range), unless noted otherwise.
Number missing body composition data for HIV-infected (height = 45, weight = 63, body fat and fat free mass = 213, arms = 263, chest = 259, waist = 256, hip = 259, thigh = 257, HIV-1 RNA = 37, any ART and HAART use = 45) and HIV-negative (height = 16, weight = 19, body fat and fat free mass = 63, arms = 69, chest = 67, waist = 69, hip = 69, thigh = 67).
p value from Wilcoxon or χ2 test, as appropriate.
Thirty-three women reporting other racial groups were combined with black.
HAART is defined as taking: (a) two or more nucleoside reverse transcriptase inhibitors (NRTIs) in combination with at least one protease inhibitor (PI) or one non-nucleoside reverse transcriptase inhibitor 9NNRTI); (b) one NRTI in combination with at least one PI and at least one NNRTI; (c) a regimen containing ritonavir and saquinavir in combination with one NRTI and no NNRTIs; or (d) an abacavir-containing regimen of three or more NRTIs in the absence of both PIs and NNRTIs.
NA, not available; ART, antiretroviral therapy; HAART, highly active antiretroviral therapy.